1. Home
  2. ONMD vs IXHL Comparison

ONMD vs IXHL Comparison

Compare ONMD & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMedNet Corp

ONMD

OneMedNet Corp

N/A

Current Price

$0.59

Market Cap

42.1M

Sector

N/A

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

N/A

Current Price

$3.58

Market Cap

37.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ONMD
IXHL
Founded
2006
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
42.1M
37.0M
IPO Year
2021
2024

Fundamental Metrics

Financial Performance
Metric
ONMD
IXHL
Price
$0.59
$3.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
810.4K
78.5K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
83.33
N/A
EPS
N/A
N/A
Revenue
$1,359,000.00
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
111.35
N/A
52 Week Low
$0.49
$0.16
52 Week High
$4.22
$6.39

Technical Indicators

Market Signals
Indicator
ONMD
IXHL
Relative Strength Index (RSI) 43.19 67.22
Support Level $0.58 $2.79
Resistance Level $0.83 $3.68
Average True Range (ATR) 0.07 0.14
MACD -0.01 0.07
Stochastic Oscillator 16.98 91.67

Price Performance

Historical Comparison
ONMD
IXHL

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: